Trading partners needs an appropriate systems to conduct interoperable, electronic tracing at the package level, while helping ensure continued patient access to prescription drugs.
This is the total amount allocated to Safe Tracking: Ensuring Access to Prescription Medications..
Create a system that could identify and trace prescription drugs without require a centralized system to hold the information.
No dependencies.
All research and software architecture documentation, as well as the prototype, will be made public. operated under a open source GNU General Public License
>> SDG SELECTION:
>> PHDI SELECTION:
The following report is applied for the selected Planetary pressures-adjusted Human Development Index:
'''
Mexico is ranked 86 (Human Development Index) and when adjusted for the Planetary pressures is ranked 65 a rise of 21.
In 2021 it had a Human Development Index (HDI) value of 0.758 that when adjusted for the Planetary pressures-adjusted HDI (PHDI) had a value of 0.704, a difference of 7.12.
The Planetary Pressures adjustment factor of 0.93 is made up of the SDG9.4 Carbon dioxide emissions per capita (production) 2020 of 2.77 tonnes (indexed value 0.96), and the SDG8.4 and 12.2 Material footprint per capita of 10.85 tonnes (indexed value 0.90).
For more information about the details of the PHDI please reference:
https://hdr.undp.org/planetary-pressures-adjusted-human-development-index#/indicies/PHDI
https://hdr.undp.org/system/files/documents/phdi2020technicalnotespdf.pdf
The specific SDG targets
https://indicators.report/targets/9-4/
https://indicators.report/targets/8-4/
https://indicators.report/targets/12-2/
Source data:
https://hdr.undp.org/sites/default/files/2021-22_HDR/HDR21-22_Statistical_Annex_PHDI_Table.xlsx (table 7)
'''
#proposertoolsdg
Context.
The DSCSA outlines requirements for enhanced drug distribution security, which include the steps to achieve interoperable, electronic tracing of products at the package level.
These requirements for enhanced drug distribution security go into effect on November 27, 2023.
The FDA sets forth enhanced drug distribution security requirements for trading partners, including adherence to standards established by FDA for the exchange of transaction information and transaction statements in a secure, interoperable, electronic manner and the verification of product at the package level.
WHAT PRODUCTS DOES THIS SOLUTION ADDRESS?
In general, a product is a prescription drug in a finished dosage form for administration to a patient without requiring substantial further manufacturing, such as capsules, tablets, and lyophilized products before reconstitution.
WHAT TRANSACTIONS DOES THIS SOLUTION ADDRESS?
In general, a transaction is defined as a transfer of product between persons in which a change of ownership occurs.
THE SOLUTION.
Create an interoperable system that could identify and trace prescription drugs without require a centralized system to hold the information.
An interoperable system means the ability to exchange transaction history, transaction information, and transaction statements accurately, efficiently, and consistently among trading partners; and for a subsequent purchaser’s system, process, or practice to successfully capture and maintain the transaction history, transaction information, and transaction statements, regardless of whether they are provided in a paper or electronic format.
The proposal consists of 3 stages:
1) System Architecture and Design.
I will create a MVP for a system for trading partners to exchange transaction information and transaction statements, which generally must include package level product identifiers for each package included in the transaction.with the following features:
In addition,this system must also utilize data standards that facilitate a uniform process or methodology for product tracing and ensure the protection of confidential commercial information and trade secrets to protect such information should not be limited to adhering to EPCIS, but should also include using individual system(s) and procedure(s), and business practices that ensure the confidentiality of such information.*
2) Prototype Implementation.
This proposal aims to develop a ‘MVP’ representing a fully interoperable system for trading partners. Therefore, this proposal evaluates all architecture components in Cardano and applies a implementation in an experimental setting to ensure their implementation ability.
3) Testing: In order to evaluate the MVP , I will test using an example of the industry, at least simulation on the testnet. I did a little consultation on lidonation , I can see that 190 proposals have been approved in catalyst related to healthcare. I will contact some of them in order to participate and test the prototype.
After examining the results of the proposal, I'll spotlight important findings. Finally, I'll summarize the current limitations of the system and suggest recommendations for future steps.
In what way will the success of the project bring value to the Cardano Community?
How I will measure this impact?
System Performance Metrics:
User Feedback and Adoption Rates:
How I will share the outputs and opportunities that result from your project?
I'm going to talk a little bit about who I am, I'm originally from Mexico, I'm in Cardano for a little more than two years, I got funding in project catalyst fund7 with the proposal called "Support small farmers in Latam".
I was able to successfully delivered and completet the proposal, also in project catalysat I have participated as a reviewer in fund 8, 9 and in the last fund as a level 1 reviewer with a total of 80 proposals reviewed last fund.
As a member of the Latam Cardano Community, I have participated in educational content with Universities in Mexico.
I participated in organizing two CIP-1694 workshops in Mexico, in the Pan-latam workshop in Uruguay and participating in the final workshop in Edinburgh.
Regarding prototype development, for the fund 7 proposal I submitted, I had to make a prototype capable of mining tokens, transferring them and creating Cardano wallets.
Milestone 1: System Architecture and Design.
Main activities.
Acceptance Criteria.
Outputs.
Documentation accessible via google drive.
Timeline: March 2024- June 2024
Budget: 23,000 ADA
Milestone 2: Prototype Implementation.
This milestone involves the practical implementation of a Minimum Viable Product (MVP) to represent a fully interoperable system for trading partners in the pharmaceutical supply chain. The focus is on evaluating all architecture components in Cardano and applying the implementation in an experimental setting to ensure their functionality.
Main Activities.
Acceptance Criteria.
Outputs.
Timeline: June 2024- November 2024
Budget: 39,000 ADA
Milestone 3: Testing
The evaluation of the developed MVP through testing, utilizing an industry-specific example. The testing process will include simulations on the testnet to ensure the functionality and effectiveness of the interoperable system, collaboration with healthcare-related proposals from Catalyst will be initiated to involve real-world scenarios and gather valuable feedback.
Main Activities.
Acceptance Criteria.
Outputs.
Timeline: November 2024- February 2025
Budget: 17,000 ADA
Final Milestone: Project Completion and Evaluation.
This milestone marks the conclusion of the project, involving a thorough examination of the results and key findings. The final project completion report and video will be created to summarize the overall journey, outcomes, and limitations of the system.
Main Activities.
Acceptance Criteria.
Outputs.
Timeline: February 2025- March 2025
Budget: 7,500 ADA
Cristian Rojas velez . Twitter : @CrisRo0787- Project Manager , researcher, in charge of documentation and reporting, architecture design and prototype development.
I plan to commit a minimum of 20 hours per week on average to this project over the course of 12 months. I believe the proposed timeline is reasonable, and the clearly outlined milestones provide a structured framework for me to deliver the project satisfactorily.
System Architecture and Design.
Prototype Implementation.
Testing.
Project Completion and Evaluation.
Reserve: (in case of unforeseen expenses or adjustments): 5000 ADA.
To calculate the ADA price to be taken for the budget and its monthly volatility, I used the following formulas:
ADA price = the average price over the last 365 days = 0.32 USD
Monthly volatility = The standard deviation of that same sample (0.3137) multiplied by the square root of 30 (5.477) = 0.17 = 17%.
Then the required ADA will be =(85000 ADA ) * 1.17 = 99,450 ADA
The project encompasses system architecture and design, prototype implementation, testing, and project completion. Each phase involves a substantial amount of work, which justifies the overall cost.
The budget includes development labor for 500 hours, reflecting the effort required to design and implement a system. The hourly rate appears reasonable. 32,500 ADA , the time to develop the prototype I estimate it in 5 months , dedicating 25 hours a week, it would be a total of 500 hours , which gives an hourly wage of 20 usd approximately.
The other important expense is the design of the architecture for which 4 months are destined, in this case 20 hours a week for a total of 320 hours, which gives a salary per hour of 17 usd approximately.
Allocating funds for community outreach, user training materials, and a dedicated website demonstrates a commitment to engaging and educating the Cardano community.